TP53 and cancer: Neoplastic intervention: Cancer-associated pathways (p53 signaling, Viral carcinogenesis, Platinum drug resistance) converged with cellular homeostasis pathways (Apoptosis, Necroptosis), indicating multi-target oncological effects through simultaneous induction of tumor cell death and drug resistance reversal.